The store will not work correctly when cookies are disabled.
(4-Hydroxyphenyl)(3,9-diazaspiro[5.5]undecan-3-yl)methanone
ID: ALA5202155
PubChem CID: 168292438
Max Phase: Preclinical
Molecular Formula: C16H22N2O2
Molecular Weight: 274.36
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(c1ccc(O)cc1)N1CCC2(CCNCC2)CC1
Standard InChI: InChI=1S/C16H22N2O2/c19-14-3-1-13(2-4-14)15(20)18-11-7-16(8-12-18)5-9-17-10-6-16/h1-4,17,19H,5-12H2
Standard InChI Key: ZKUGCZVZAXUEDS-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
22.4104 -13.1192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1254 -13.5308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8375 -13.1232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8407 -12.2983 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1257 -11.8826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4075 -12.2960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9846 -13.1192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9846 -13.9465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.6991 -14.3539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4136 -13.9465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6991 -12.6994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5546 -11.8845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5568 -11.0571 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.2648 -12.2961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2632 -13.1203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9750 -13.5321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6889 -13.1207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6866 -12.2934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9742 -11.8854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4021 -13.5316 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 1 0
7 11 1 0
8 9 1 0
9 10 1 0
10 1 1 0
1 11 1 0
4 12 1 0
12 13 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 14 1 0
17 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 274.36 | Molecular Weight (Monoisotopic): 274.1681 | AlogP: 2.00 | #Rotatable Bonds: 1 |
Polar Surface Area: 52.57 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.46 | CX Basic pKa: 10.34 | CX LogP: 0.08 | CX LogD: -0.86 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.82 | Np Likeness Score: -0.41 |
References
1. Bavo F, de-Jong H, Petersen J, Falk-Petersen CB, Löffler R, Sparrow E, Rostrup F, Eliasen JN, Wilhelmsen KS, Barslund K, Bundgaard C, Nielsen B, Kristiansen U, Wellendorph P, Bogdanov Y, Frølund B.. (2021) Structure-Activity Studies of 3,9-Diazaspiro[5.5]undecane-Based γ-Aminobutyric Acid Type A Receptor Antagonists with Immunomodulatory Effect., 64 (24.0): [PMID:34908407] [10.1021/acs.jmedchem.1c00290] |